Concepedia

Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study

Ohad Atia, Zivia Shavit-Brunschwig, Diane R. Mould, Ronen Stein, Manar Matar, Marina Aloi, Oren Ledder, Gili Focht, Darja Urlep, Jeffrey S. Hyams,

˜The œLancet. Gastroenterology & hepatology · 2022 · 62 citations · 31 references

DOI

Concepts

References

31

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

Arie Levine, Sibylle Koletzko, Dan Turner et al. · Journal of Pediatric Gastroenterology and Nutrition · 2013 · 1.4K citations · Full text

, , +15

Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study

Dan Turner, Anthony Otley, David R. Mack et al. · Gastroenterology · 2007 · 1.1K citations · Full text

, , +12

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts et al. · Gastroenterology · 2014 · 705 citations · Full text

, , +15